Skip to content
Equity Capital Market
  • Privacy Policy
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • IPO & Public Offerings
  • Economy & Macro
  • Latest
  • Stock Market
  • Market Education
  • Energy & Commodities
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact
  • Guides
    • Options guides
    • Bonds & Rates guides
    • Valuation guides
    • IPOs guides

iam ipo

Iambic Therapeutics Files Form S-1 for Nasdaq IPO Under IAM

November 20, 2026September 22, 2026 by Bruno M.
AI-generated editorial image: Minimalist scientific laboratory desk with clean molecular models and institutional workspace

Iambic Therapeutics filed a Form S-1 with the SEC to list on Nasdaq under IAM, backed by Nvidia and Coatue, with $207.9M in cash and clinical HER2 data.

Categories Artificial Intelligence, IPO & Public Offerings

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Nvidia Q3 FY27: $115.8B Revenue, $130B Q4 Outlook
  • Vertical Spreads Explained: How Debit and Credit Spreads Work
  • Intuit Sells Mailchimp to Bending Spoons for $3.68 Billion
  • Anthropic (ANT) Lock-Up Schedule: 23 Release Dates and the Quiet Period
  • Walmart Q3 FY27: E-Commerce Up 17%, Guidance Raised Again

Subscribe to Our Newsletter

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

  • Privacy Policy
  • Editorial Policy
  • Corrections Policy
  • Financial Disclaimer
  • Contact
  • About Bruno M.
  • Investor Tools
© 2026 Equity Capital Market • Built with GeneratePress